✦ LIBER ✦

A Randomized Trial Comparing Anti-Interleukin-2 Receptor Antibody and Placebo for Immunosuppressive Therapy After OLT

✍ Scribed by J.M Langrehr; M Glanemann; A Schneller; U Neumann; O Guckelberger; R Lohmann; J Klupp; S Jonas; M Knoop; H Lobeck; H Schlag; H Keck; U Settmacher; W.O Bechstein; P.J Neuhaus

Book ID: 117236156
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 138 KB
Volume: 30
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(98)00309-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-IL-2 receptor BT563 versus placebo:

Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantation

✍ M Glanemann; J.M Langrehr; R Raakow; O Guckelberger; R Lohmann; J Klupp; H Lobec 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Anti–interleukin-6 receptor antibody the

Anti–interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled study

✍ Rainer H. Straub; Peter Härle; Seizo Yamana; Takemasa Matsuda; Kiyoshi Takasugi; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 2 views

Therapeutic benefit of blocking interleu

Therapeutic benefit of blocking interleukin-6 activity with an anti–interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double-blind, placebo-controlled, dose-escalation trial

✍ E. H. S. Choy; D. A. Isenberg; T. Garrood; S. Farrow; Y. Ioannou; H. Bird; N. Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views

Interleukin-2 receptor antibody (basilix

Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: A protocol with early elimination of steroids and reduction of tacrolimus dosage

✍ Chi Leung Liu; Sheung Tat Fan; Chung Mau Lo; See Ching Chan; Irene O. Ng; Ching 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

A prospective evaluation was performed to study the potential benefits of the use of interleukin-2 receptor antibody (IL-2Rab) in the induction therapy with early elimination of steroid and reduction of tacrolimus dosage in liver transplant recipients among whom 94% had chronic hepatitis B infection

Effect of anti-IL-1β antibody (canakinum

Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial

✍ A. Rissanen; C. P. Howard; J. Botha; T. Thuren; for the Global Investigators 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Comparative efficacy and durability of c

Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: Design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up

✍ Robin B. Jarrett; Michael E. Thase 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 374 KB